Unicorn Nest news
Hello Heart Completes $45M Series C
– Hello Heart, a heart health digital therapeutics solution, has completed a $45m Series C led by IVP.
– Hello Heart’s existing investors, including Khosla Ventures, BlueRun Ventures, Maven Ventures, and Resolute Ventures also participated in the round.
– Hello Heart’s mission is to empower people to manage and improve their heart health using digital technology.
Unicorn Nest news
Bioheng Biotech Raised $80 million in Series B Financing to Advance Allogeneic Immuno-Cell Therapies
– Bioheng Biotech raised $80m in Series B financing.
– The round was led by GL Ventures, the venture capital unit of Hillhouse Capital, Decheng Capital and Octagon Capital, with the participation of BlueRun Ventures and Shenzhen Capital Group Company.
– Proceeds will be used to advance R&D capabilities, process development and clinical trials.
– Bioheng is dedicated on developing novel cellular immunotherapy for cancer.